Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer

  1. Calvo, R.
  2. Jiménez, R.Ma.
  3. Trocóniz, I.F.
  4. Suárez, E.
  5. Gonzalo, A.
  6. Lucero, Ma.L.
  7. Raczka, E.
  8. Orjales, A.
Aldizkaria:
Cancer Chemotherapy and Pharmacology

ISSN: 0344-5704

Argitalpen urtea: 1998

Alea: 42

Zenbakia: 5

Orrialdeak: 418-422

Mota: Artikulua

DOI: 10.1007/S002800050839 GOOGLE SCHOLAR